Clinical Trial Update: Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage [Phase 4]

View source ↗

Summary

This Phase 4 study evaluates safety and efficacy of different regimens for reintroducing anti-tuberculosis drugs in patients who developed liver injury from TB …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Liver Injury
• Tuberculosis

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Drug Induced Hepatotoxicity, Tuberculosis | Phase 4 | Status: COMPLETED